3174 Tumor suppressors p53 and ARF control oncogenic potential of triple-negative breast cancer cells by regulating RNA editing enzyme ADAR1

OBJECTIVES/SPECIFIC AIMS: Triple-negative breast cancer (TNBC) accounts for one-fifth of the breast cancer patient population. The heterogeneous nature of TNBC and lack of options for targeted therapy make its treatment a constant challenge. The co-deficiency of tumor suppressors p53 and ARF is a si...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Che-Pei Kung, Emily Bross, Emily Bramel, Eric Freeman, Thwisha Sabloak, Catherine Kuzmicki, Mike Benjamin, Leonard Maggi, Jason Weber
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Cambridge University Press 2019-03-01
Reeks:	Journal of Clinical and Translational Science
Online toegang:	https://www.cambridge.org/core/product/identifier/S205986611900061X/type/journal_article
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!